BRPI0916775A2 - compostos tricíclicos, um processo para seu preparo e composições farmacêuticas contendo os mesmos - Google Patents

compostos tricíclicos, um processo para seu preparo e composições farmacêuticas contendo os mesmos

Info

Publication number
BRPI0916775A2
BRPI0916775A2 BRPI0916775-7A BRPI0916775A BRPI0916775A2 BR PI0916775 A2 BRPI0916775 A2 BR PI0916775A2 BR PI0916775 A BRPI0916775 A BR PI0916775A BR PI0916775 A2 BRPI0916775 A2 BR PI0916775A2
Authority
BR
Brazil
Prior art keywords
preparation
same
pharmaceutical compositions
compositions containing
tricyclic compounds
Prior art date
Application number
BRPI0916775-7A
Other languages
English (en)
Inventor
Casara Patrick
Le Diguarher Thierry
Durand Didier
Geneste Olivier
Hickman John
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of BRPI0916775A2 publication Critical patent/BRPI0916775A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0916775-7A 2008-07-15 2009-07-10 compostos tricíclicos, um processo para seu preparo e composições farmacêuticas contendo os mesmos BRPI0916775A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0804014A FR2933983B1 (fr) 2008-07-15 2008-07-15 Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR08/04014 2008-07-15
PCT/FR2009/000855 WO2010007248A2 (fr) 2008-07-15 2009-07-10 Nouveaux derives tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BRPI0916775A2 true BRPI0916775A2 (pt) 2018-02-14

Family

ID=40404284

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916775-7A BRPI0916775A2 (pt) 2008-07-15 2009-07-10 compostos tricíclicos, um processo para seu preparo e composições farmacêuticas contendo os mesmos

Country Status (14)

Country Link
US (1) US20110112104A1 (pt)
EP (1) EP2303880A2 (pt)
JP (1) JP2011528028A (pt)
KR (1) KR20110030686A (pt)
CN (1) CN102149714A (pt)
AR (1) AR072745A1 (pt)
AU (1) AU2009272612A1 (pt)
BR (1) BRPI0916775A2 (pt)
CA (1) CA2730516A1 (pt)
EA (1) EA201100188A1 (pt)
FR (1) FR2933983B1 (pt)
MA (1) MA32560B1 (pt)
MX (1) MX2011000533A (pt)
WO (1) WO2010007248A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX364558B (es) * 2013-10-04 2019-04-29 Univ Basel INHIBIDORES DE PI3K Y mTOR CONFORMACIONALMENTE RESTRINGIDOS.
TWI796353B (zh) * 2017-08-15 2023-03-21 美商阿吉歐斯製藥公司 丙酮酸激酶調節劑及其用途
WO2020094084A1 (zh) * 2018-11-07 2020-05-14 南京明德新药研发有限公司 作为ret抑制剂的三并环衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688950A (en) * 1996-04-23 1997-11-18 Neurogen Corporation Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
CA2604284A1 (en) * 2005-04-28 2006-11-02 Supergen, Inc. Protein kinase inhibitors
FR2912145B1 (fr) * 2007-02-02 2009-03-06 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MA32560B1 (fr) 2011-08-01
CA2730516A1 (fr) 2010-01-21
MX2011000533A (es) 2011-02-22
FR2933983B1 (fr) 2010-08-27
FR2933983A1 (fr) 2010-01-22
CN102149714A (zh) 2011-08-10
US20110112104A1 (en) 2011-05-12
JP2011528028A (ja) 2011-11-10
WO2010007248A2 (fr) 2010-01-21
EP2303880A2 (fr) 2011-04-06
WO2010007248A3 (fr) 2010-04-08
AU2009272612A1 (en) 2010-01-21
KR20110030686A (ko) 2011-03-23
AR072745A1 (es) 2010-09-15
EA201100188A1 (ru) 2011-08-30

Similar Documents

Publication Publication Date Title
AR078163A1 (es) Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes
WO2008091670A3 (en) Organic semiconductor materials and precursors thereof
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
EP4295841A3 (en) Sulfur (vi) fluoride compounds and their use in click-reaction
BRPI0916995B8 (pt) compostos orgânicos, seu uso, e composição farmacêutica
MY144633A (en) New tricyclic derivatives, method of preparing same and pharmaceutical compositions containing them
UY31524A1 (es) Nuevos compuestos 010
WO2011117591A3 (en) Amine synergists and their use in radiation curing
UY30206A1 (es) Derivados de diamina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
CU23754B7 (es) Procedimiento para la preparación de 4-{4-[cloro-3-(trifluorometil)fenil]amino}carbonil)amino]fenoxi}-n-metilpiridina-2-carboxamida y su sal tosilato.
ATE523514T1 (de) Tricyclische triazolische verbindungen
MX2010001170A (es) Derivados de imidazolona, metodo de preparacion de los mismos y uso biologico de los mismos.
AR080596A1 (es) Compuestos alquilamido y composiciones farmaceuticas
EA201070876A1 (ru) Трициклические соединения, обладающие антагонистической активностью по отношению к кортикотропин-высвобождающему фактору, и содержащие их фармацевтические композиции
GEP20125548B (en) New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them
DOP2009000073A (es) Inhibidores de cinasa que catalizan la transferencia de fosforilo y/o que enlazan nucleótidos atp/gtp.
BRPI0815610A2 (pt) Compostos de alcoxipoliéster, composições e métodos para uso dos mesmos
BRPI0513858B8 (pt) compostos de benziltriazolona como inibidores não-nucleosídeos da transcriptase reversa, seu processo de preparação, seu uso e composição farmacêutica que os compreende
GB0525673D0 (en) Organic compounds
BRPI0916775A2 (pt) compostos tricíclicos, um processo para seu preparo e composições farmacêuticas contendo os mesmos
BRPI0509912A (pt) compostos, processo para a preparação dos mesmos, composição farmacêutica, e, uso de um composto
WO2008062167A3 (en) Melatonin derivatives and their use as antioxidants
SG168482A1 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
WO2008155594A3 (en) Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
WO2008059068A3 (de) Carbonyl-substituierte titanocene

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]